Top Biotech Companies in Denver & Boulder, CO (64)
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. Whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or...
Agilent Technologies's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry and company materials consistently place Agilent among the top global players in analytical instrumentation—especially in chromatography and mass spectrometry—and as a frequent short‑list vendor for regulated and R&D labs. Recognition such as Instrument Business Outlook’s “Company of the Year” supports this standing.
Diversified Revenue Streams: The portfolio spans instruments, software/informatics, consumables, and services (Agilent CrossLab), with end‑to‑end workflows and specialty CDMO contributions providing multiple revenue levers. This breadth increases switching costs and drives recurring revenue that helps balance capital‑equipment cycles.
Resilient & Sustainable Growth: After a FY2024 decline, revenue returned to growth in FY2025 and continued in Q1 FY2026, with guidance pointing to mid‑single‑digit core growth and margin expansion. CrossLab’s steady growth and an instrument replacement cycle are cited as continuing supports.
EcoGen BioSciences is a producer, manufacturer and supplier of compliant specialty hemp ingredients globally. Our platform of in-house processing and extraction provides innovative bulk and private label service opportunities for our customers. Curated from our processing and extraction facilities, our team has developed a broad range of the highest quality hemp derived cannabinoids and customized formulations for the beverage, food, cosmetics,...
Enrich is the leader in biotech and pharmaceutical portfolio management software, used in over half of the top 10 life sciences companies to value and manage portfolios of high risk, high investment assets. Our proprietary suite of tailored analytics and flexible on-demand visualizations are ideally suited for portfolio management.
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to...
Ensign-Bickford Industries, Inc. (EBI), founded in 1836, is a privately-owned high technology conglomerate focused in space & defense, pet food science, and biotechnology. We participate in businesses that are relevant to the future of the world and have multigenerational growth prospects. EBI companies are unified by a common shared operating system and a common set of values.
Our DATA for LIFE® mantra celebrates Pyxant Labs’ participation in an industry which saves lives. We fulfill an essential role in the drug development process. We have developed seminal capabilities directly supporting a cure for hepatitis, antiviral therapeutics for HIV, a fundamental understanding of Alzheimer’s Disease, antisense therapeutics, and now therapeutics for COVID-19. Founded in 2000, Pyxant Labs is a leading...
What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Our goal is to discover, develop, manufacture, and commercialize transformative...
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
Vitrolife Group is a global provider of medical devices and genetic testing services for reproductive health and assisted reproduction. The company develops, manufactures, and markets fertility products and advanced software, including time-lapse incubators and embryo evaluation systems. Its mission is to help people fulfill the dream of having a healthy baby, supporting fertility clinics and patients worldwide through innovation and...
Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit, multispecialty academic medical center that integrates clinical and hospital care with research and education. Founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation, Cleveland Clinic has become one of the largest and most respected hospitals in the...
Cleveland Clinic's Top Stability & Growth Strengths
Strong Revenue Growth: Operating revenue grew from about $15.9 billion in 2024 to roughly $18 billion in 2025 alongside an operating margin above 4%. Patient encounters also reached a record, rising from about 15.7 million in 2024 to nearly 16 million in 2025.
Market Expansion: The system is adding capacity across geographies, including a $340 million expansion in Avon, a planned private cancer hospital in London by 2027, and continued growth at Cleveland Clinic Abu Dhabi. Scale includes 23 hospitals and 280 outpatient locations as of year‑end 2024, with rising international patient volumes.
Strong Brand Reputation: Global and national rankings place the organization among the top hospitals, including Newsweek’s No. 2 worldwide ranking and continued U.S. News Honor Roll status in 2025–2026. Specialty depth remains broad, with numerous top national placements and No. 1 in Ohio.
Amerita, Inc. is a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost-effective delivery settings, a growing bio-pharmaceutical pipeline of
At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.
Materion (NYSE: MTRN) is one of the world’s premier advanced materials solutions providers. At Materion, we are committed to developing, manufacturing and marketing highly engineered advanced materials for global customers across a wide range of markets, including consumer electronics, defense and science, industrial and aerospace, automotive electronics, telecommunications infrastructure, appliances, medical and energy. Our products, processes and expertise help enable...
The SmartTab technology platform is a personalized wireless drug delivery solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is focused on the development of three drug delivery systems: TargetTab™, InjectTab™ and MultiTab™. Providing novel effective therapies to improve patient outcomes and compliance.
GT Molecular was created to develop new molecular detection technology for cancer research and harmful pathogen detection. We have recently focused these powerful tools on the detection of SARS-CoV-2 in wastewater to support communities around the country with their monitoring programs. Ultrasensitive Molecular Assays, Digital PCR and qPCR Tests End-to-End solutions for cancer detection and waterborne pathogens including SARS-CoV-2. Detect as...
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) and clinical-stage therapeutics developer. The company helps scientists, physicians, biotechnology and pharmaceutical companies, and patient groups bring life-changing gene therapies from concept to patients. Its end-to-end capabilities include plasmid and AAV manufacturing, process and analytical development, cGMP production, fill and finish, and integrated regulatory support for transformative medicines...
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers...
Bio-Techne's Top Stability & Growth Strengths
Profitability: Adjusted EPS and operating margins expanded despite muted top-line trends, including a 31.1% adjusted operating margin in the most recent quarter. Cost and productivity actions supported margin improvement even as sales were flat year over year.
Strong Market Position & Advantage: Leadership in niches such as immunoassays and high-quality proteins (R&D Systems), RNA-ISH (RNAscope), and automated protein analysis (ProteinSimple) underpins competitive strength. In-house manufacturing control over most reagents reinforces quality and consistency across core categories.
Future-Ready Strategy: Focus on cell therapy, proteomic instrumentation, spatial biology, and precision diagnostics has expanded as a share of revenue and aligns with high-growth workflows. Acquisitions and strategic stakes (e.g., Lunaphore, Wilson Wolf/ScaleReady) position the portfolio for emerging demand.
Cerapedics is a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair by healing bones faster and at higher rates, utilizing proprietary technology such as the P-15 Peptide.
At Accure, we are wholly committed to developing revolutionary solutions to provide a long- lasting, durable treatment for acne. We know that acne can have a devastating social, psychological, physical, and economic impact on patients around the world. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.
